Key result
A repeat transcatheter aortic valve replacement (TAVR) was described in a patient who previously had a valve-in-valve procedure in an aortic homograft.
Case Report (n=1)
This case report highlights the feasibility and challenges of performing a repeat TAVR in a patient with a prior valve-in-valve procedure within an aortic homograft.
May support technical feasibility of repeat TAVR after valve-in-valve homograft; leaves open durability and selection questions.
In recent years, the use of transcatheter aortic valve replacement (TAVR) has extended beyond the treatment of native aortic valve stenosis in patients with high surgical risk. TAVR is increasingly being performed for bioprosthetic aortic valve failure, i.e., the valve-in-valve (VIV) procedure. Establishing the success of a VIV procedure can be challenging in these cases. Furthermore, the limited availability of prostheses sizes further complicates the management of these patients. We present an unusual case of a repeat TAVR in a patient who previously had a VIV procedure in an aortic homograft.
No takes yet. Share an insight, caveat, or question.
Hollander et al. (2016) conducted a case report in Bioprosthetic aortic valve failure (n=1). Repeat transcatheter aortic valve replacement (TAVR) was evaluated. A repeat transcatheter aortic valve replacement (TAVR) was described in a patient who previously had a valve-in-valve procedure in an aortic homograft.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: